trending Market Intelligence /marketintelligence/en/news-insights/trending/PsQGjl2HPQ4M5EWpUcJlzQ2 content esgSubNav
In This List

NanoString Technologies prices common stock offering


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

NanoString Technologies prices common stock offering

NanoString Technologies Inc. priced a public offering of common shares at $23 each.

The Seattle-based company is selling 2.5 million common shares under the offer, while private equity fund Clarus Lifesciences II LP, a NanoString stockholder, will sell 2 million shares. NanoString will not receive proceeds from the sale by Cambridge, Mass.-based Clarus.

NanoString also granted underwriters a 30-day option to buy up to an additional 675,000 common shares at the same price.

The company plans to use proceeds for working capital and general corporate purposes. The offer is expected to close on or about March 22.

J.P. Morgan, UBS Investment Bank and Cowen are acting as joint book-running managers for the offering, while Baird is acting as lead manager.

NanoString Technologies is a provider of life science tools for translational research and molecular diagnostic products.